HEALTH● LOW3d ago · Oct 24, 2026, 5:38 AM
U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad
The Hindu · south asia
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH16m agoMarijuana legalization linked to rise in heart-related hospitalizations, study findsThe HillHEALTH17m agoGonzalo Bonadeo revealed how he lost over 60 kilos: the medical warning that changed his lifeClarínHEALTH52m agoWeight-loss drugs linked to these deficiencies reported by users, research revealsThe Independent WorldHEALTHBREAKING1h agoEbola cases in DR Congo surpass 10,000 in fastest-growing outbreakAl Jazeera [en]